GoHealth, Inc. - Class A Common Stock (GOCO)

GoHealth Q2 2025 results miss revenue estimates at $94.05M, with a net loss of -$54.3M. Adjusted EPS improved but remains negative. Stock dips as strategic moves aim to boost liquidity.

Shares of eHealth, GoHealth and SelectQuote plummeted on Thursday. A sweeping federal complaint alleges the companies took part in a multi-year Medicare fraud scheme.

GOCO stock results show that GoHealth beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.